Home » Dr. Marilyn Hockenberry awarded research funding
September 2, 2009 – Baylor College of Medicine
Marilyn Hockenberry, Ph.D., and her research team at the Texas Children’s Cancer Center have received five years of funding from the National Institute of Nursing Research/National Institutes of Health to investigate the mechanisms of treatment-related central nervous system injury and its effects on cognitive and behavioral outcomes in children with acute lymphoblastic leukemia.
Hockenberry’s research team has worked for the past 10 years with Dr. Ki Moore from the University of Arizona to explore central nervous treatment toxicities in children with cancer.
This most recent grant will focus on how methotrexate damages non-malignant cells in the central nervous system and how this damage results in cognitive and academic problems. They hope this work will lead to early interventions to prevent cognitive and academic problems for these children in the future.